Haemonetics Corporation (HAE) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Haemonetics Corporation.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.976 -- 00:00:07.883 Good day, and thank you for standing by. Welcome to the Q4 2025 Humanitics 00:00:08.547 -- 00:00:13.955 Corporation Earnings Conference Call. At this time, all participants are on a listen-only 00:00:13.955 -- 00:00:19.443 mode. After the speaker's presentation, there'll be a question and answer session. 00:00:19.443 -- 00:00:23.789 To ask a question during the session, you'll need to press star 11 on your telephone. 00:00:23.789 -- 00:00:27.394 You will then hear an automated message advising your hand is raised. 00:00:27.394 -- 00:00:30.338 To answer your question, please press star 11 again. 00:00:30.338 -- 00:00:33.822 Please be advised that today's conference is being recorded. 00:00:33.822 -- 00:00:37.767 I would now like to turn the conference over to Ola Gayed, Vice President of Investor 00:00:37.767 -- 00:00:41.609 Relations and Treasury. Please go ahead. 00:00:42.132 -- 00:00:46.457 Good morning, and thank you all for joining us for Humanetics' fourth quarter and fiscal 00:00:46.457 -- 00:00:51.843 year 2025 conference call and webcast. I'm joined today by Chris Simon, 00:00:51.843 -- 00:00:56.944 our CEO, and James Durecka, our CFO. This morning, we posted our 00:00:56.944 -- 00:01:02.151 fourth quarter and fiscal year 2025 results to our investor relations website, along 00:01:02.151 -- 00:01:06.397 with additional supplemental tables that support some of the assumptions within our fiscal 00:01:06.397 -- 00:01:10.764 year 2026 guidance included in our earnings release. 00:01:10.764 -- 00:01:16.011 These supplemental tables help reconcile the projected fiscal year 2026 growth rates 00:01:16.011 -- 00:01:17.634 of electrophysiology, 00:01:17.634 -- 00:01:20.458 coronary, and peripheral procedures in the U.S. 00:01:20.458 ...